Growth Metrics

Nutex Health (NUTX) Return on Capital Employed (2016 - 2026)

Nutex Health (NUTX) has disclosed Return on Capital Employed for 16 consecutive years, with 0.37% as the latest value for Q1 2026.

  • For Q1 2026, Return on Capital Employed fell 4.0% year-over-year to 0.37%; the TTM value through Mar 2026 reached 0.37%, down 4.0%, while the annual FY2025 figure was 0.44%, 9.0% up from the prior year.
  • Return on Capital Employed hit 0.37% in Q1 2026 for Nutex Health, up from 0.35% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.64% in Q1 2022 and bottomed at 1.17% in Q2 2023.
  • Average Return on Capital Employed over 5 years is 0.06%, with a median of 0.03% recorded in 2024.
  • Year-over-year, Return on Capital Employed crashed -179bps in 2023 and then surged 111bps in 2024.
  • Nutex Health's Return on Capital Employed stood at 1.08% in 2022, then skyrocketed by 92bps to 0.08% in 2023, then skyrocketed by 498bps to 0.33% in 2024, then grew by 6bps to 0.35% in 2025, then increased by 4bps to 0.37% in 2026.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.37%, 0.35%, and 0.5% for Q1 2026, Q4 2025, and Q3 2025 respectively.